ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 2190 • 2015 ACR/ARHP Annual Meeting

    Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Core Laboratory Validation Exercise: Comparison of Enzyme-Linked Immunosorbant Assay (ELISA) and Chemiluminescence Immunoassay (CIA)

    Maria Laura Bertolaccini1, Danieli Andrade2, Gabriella Lakos3, Rohan Willis4, Vittorio Pengo5, Alessandra Banzato6, Hannah Cohen7, Steven Krilis8, Doruk Erkan9 and on behalf of APS ACTION, 1Lupus Unit, Rayne Institute, Lupus Research Unit, The Rayne Institute, King's College London School of Medicine, St Thomas' Hospital, London, United Kingdom, 2Rheumatology, University of São Paulo, São Paulo, Brazil, 3INOVA Diagnostics, Inc., San Diego, CA, 4Department of Internal Medicine, Antiphospholipid Standardization Laboratory, Division of Rheumatology, Galveston, TX, 5Clinical Cardiology, Department of Cardiac Thoracic and Vascular Sciences, University of Padova, Padova, Italy, 6Department of Cardiac Thoracic and Vascular Sciences, Department of Cardiac Thoracic and Vascular Sciences, University of Padua, Padua, Italy, 7Hematology., University College London, LOndon, United Kingdom, 8Immunology, Allergy, and Infectious Diseases, St George Hospital, Kogarah NSW, Australia, 9Rheumatology, Barbara Volcker Center for Women and Rheumatic Diseases: Hospital for Special Surgery, New York, NY

    Background/Purpose: APS ACTION International Clinical Database and Repository was created to study the natural course of disease over 10 years in persistently aPL-positive patients with/without…
  • Abstract Number: 2534 • 2014 ACR/ARHP Annual Meeting

    Ocular Surface Temperature in Early Sjogren’s Syndrome and Established Disease

    Andreea Coca1, Ranjini Kottaiyan2, Mircea Coca3, Debbie Campbell4, Holly Hindman2 and James Aquavella2, 1Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 2Ophtalmology, University of Rochester, Rochester, NY, 3Ophtalmology, University of Texas Medical Branch, Galveston, TX, 4Allergy, Immunology and Rheumatology, Univerity of Rochester, Rochester, NY

    Background/Purpose Due to a variety of factors it is challenging to make a definite diagnosis in the early stages of Sjögren’s syndrome (SS). The ocular…
  • Abstract Number: 357 • 2014 ACR/ARHP Annual Meeting

    Development and Validation of a Diagnostic Bead-Based Multiplex Autoantibody Assay:Screening for Autoantibodies to Detect “Seronegative” Rheumatoid Arthritis

    Stefan Vordenbäumen1, Angelika Lueking2, Carmen Theek2, Ralph Brinks1, Rebecca Fischer-Betz1, Jutta Richter1, Ellen Bleck1, Jacqueline Detert3, Gerd Burmester4, Peter Schulz-Knappe2 and Matthias Schneider1, 1Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, 2Protagen AG, Dortmund, Germany, 3Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany, 4Departement of Rhe, University Medicine, Berlin, Germany

    Background/Purpose: Autoantibodies (auto-Ab) against citrullinated peptides (ACPA) and rheumatoid factor (RF) are important biomarkers in the diagnostic process of rheumatoid arthritis (RA). However, RF or…
  • Abstract Number: 2540 • 2014 ACR/ARHP Annual Meeting

    Sjö™, an Advanced Diagnostic Panel for Detection of Sjögren’s Syndrome Autoantibodies

    Mark Jasek1, Kishore Malyavantham2, Lakshmanan Suresh3, Julian Ambrus4 and Dennis Pardo5, 1Medical and Scientific Affairs, Nicox Inc, Fort Worth, TX, 2Office of Science & Technology, IMMCO Diagnostics Inc., Amherst, NY, 360 Pineview Drive, State University of New York/Buffalo, Buffalo, NY, 4Division of Allergy, Immunology and Rheumatology, Department of Medicine, State University of New York at Buffalo, Buffalo, NY, 5Professional Affairs, Nicox Inc, Fort Worth, TX

    Background/Purpose Sjögren’s syndrome (SS) is a complex autoimmune disease involving the salivary and lacrimal glands along with various systemic manifestations. It is a difficult disease to…
  • Abstract Number: 158 • 2014 ACR/ARHP Annual Meeting

    Performance of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis : Results of a Prospective Study of 112 Patients

    Pascal Zufferey1, Isabelle Fabreguet1, Roxana Valcov1, Alexandre Dumusc1 and Alexander K. So Sr.2, 1DAL, RHU/CHUV, Lausanne, Switzerland, 2Dal/Rhu, CHUV, Lausanne, Switzerland

    Background/Purpose The gold standard for diagnosing gout and CCP arthritis is the identification of monosodium urate (MSU) crystals in joint fluid. Ultrasound (US) features of…
  • Abstract Number: 2209 • 2014 ACR/ARHP Annual Meeting

    Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD

    Joachim Høg Mortensen1, Line Elberg Godskesen2, Michael Dam Jensen2, Lone Gabriels Klinge2, Jens Kjeldsen2, Aleksander Krag2, Morten Karsdal3 and Anne C. Bay-Jensen4, 1Cartilage Biomarkers and Research, Nordic Bioscience, Købehavn, Denmark, 2Odense University Hospital, Odense, Denmark, 3Research & Development, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 4Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark

     Background/Purpose: About 10 % of patients with IBD have symptoms that match both Crohn's disease (CD) and ulcerative colitis (UC), termed inflammatory bowel disease unclassified…
  • Abstract Number: 148 • 2014 ACR/ARHP Annual Meeting

    Value of Ultrasonography Parotid Glands in Patients with Suspected Primary Sjögren’s Syndrome

    Marina Oliver1, Lida Santiago2, Paula Gonzalez1, Diego Vila1, Sebastian fernandez Nacul1, Santiago Scarafia3, Marta Mamani4 and Anastasia Secco3, 1Rheumatology, Rivadavia Hospital, Buenos Aires, Argentina, 2hospital rivadavia, CABA, Argentina, 3Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 4Hospital Rivadavia, Capital Federal, Argentina

    Background/Purpose Primary Sjogren’s syndrome (pSS) is an autoimmune disorder characterised by chronic lymphocytic infiltration of exocrine tissues. Currently new non-invasive techniques are being continuously introduced…
  • Abstract Number: 2057 • 2014 ACR/ARHP Annual Meeting

    Electrophysiological Evaluation of Autonomic Nervous System and Cutaneous Silent Period in Patients with Fibromyalgia Syndrome

    Isil Ustun1, Ilker Yagci2, Gulseren Akyuz3 and Feyza Unlu,Ozkan4, 1Physical Medicine and Rehabilitation, Bagcilar Training Hospital, Istanbul, Turkey, 2Marmara Universitesi T?p Fakultesi, Istanbul, Turkey, 3Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey, 4Fatih Sultan Mehmet Training Hospital, Istanbul, Turkey

    Background/Purpose This study was designed to investigate the autonomic nervous system (ANS) and spinal inhibitory circuits in FMS by electrophysiological studies and compare the results…
  • Abstract Number: 1995 • 2014 ACR/ARHP Annual Meeting

    Design and Implementation of a Clinical Teaching Tool for Approach to Children with Suspected New Rheumatologic Diagnosis

    Kristen Hayward1 and Jennifer Hrachovec2, 1Pediatric Rheumatology, Seattle Children's Hospital, Seattle, WA, 2Clincal Effectiveness, Seattle Children's Hospital, Seattle, WA

    Background/Purpose Approximately 1 in 1000 children suffer from a rheumatologic disorder. Despite the relative frequency of these conditions, there is a shortage of pediatric rheumatologists…
  • Abstract Number: 1867 • 2014 ACR/ARHP Annual Meeting

    Mandibular Movement in Healthy Individuals from 4-17 Years of Age

    Peter Stoustrup1, Kasper Dahl Kristensen2,3, Annelise Küseler4, Thomas Klit Pedersen5,6 and Troels Herlin7, 1Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, 2Section of Orthodontics, University of Aarhus, Denmark, 8000 Aarhus, Denmark, 3Specialist Oral Health Center for Western Norway, Rogaland Stavanger, Norway, 4Section of Orthodontics, Aarhus University, Aarhus, Denmark, 5Section or Orthodontics, Aarhus University, Aarhus, Denmark, 6Department of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Assessment of mandibular movement capacity is an important part of the clinical orofacial examination of patients with juvenile idiopathic arthritis (JIA). The aim of…
  • Abstract Number: 1756 • 2014 ACR/ARHP Annual Meeting

    Molecular Diagnosis Reveals a Surprising Prevalence of Limited Gpa Among Patients with Orbital Inflammatory Diseases

    James T. Rosenbaum1, Dongseok Choi2, Christine Harrington3, Patrick Stauffer4, David Wilson5, Seema Gupta4, Roger Dailey4, John Ng4, Eric Steele4, Patrick Yeatts6, Peter Dolman7, Valerie White7, Gerald Harris8, Craig Czyz9, Jill Foster9, Deepak Edward10, Hind Alkatan10, Bobby Korn11, Don Kikkawa12, Dinesh Selva13, Sander Dubovy14, Chris Alabiad15, David Tse15, Michael Kazim16, Payal Patel16 and Stephen R. Planck17, 1OHSU, Portland, OR, 2Casey Eye Institute, Oregon Health and Science University, Portland, OR, 3Integrated Genomics, Oregon Health & Science University, Portland, OR, 4Oregon Health & Science University, Portland, OR, 5Casey Eye Institute/Ophthalmology, Oregon Health & Science University, Portland, OR, 6Ophthalmology, Wake Forest University, Winston-Salem, NC, 7University of British Columbia, Vancouver, BC, Canada, 8Medical College of Wisconsin, Milwaukee, WI, 9Ohio State Univeristy, Columbus, OH, 10King Khaled Eye Hospital, Riyadh, Saudi Arabia, 11University of California, San Diego, San Diego, CA, 12Ophthalmology, University of California, San Diego, San Diego, CA, 13Royal Adelaide Hospital, Adelaide, Australia, 14University of Miami, Miami, FL, 15Ophthalmology, University of Miami, Miami, FL, 16Columbia University, New York City, NY, 17Casey Eye Inst/Ophthalmology, Oregon Health & Science University, Portland, OR

    Background/Purpose: Gene expression profiling provides diagnostic and therapeutic information in several malignancies, but its role in evaluating inflammatory disease is relatively untested. We hypothesized that…
  • Abstract Number: 1762 • 2014 ACR/ARHP Annual Meeting

    The Muscle Biopsy Is a Useful and Noninvasive Procedure in Diagnosing Systemic Vasculitis Affecting Small-to-Medium-Sized Vessels: A Prospective Evaluation

    Takahiro Nunokawa1, Takayasu Kise1, Naoto Yokogawa2, Kota Shimada1 and Shoji Sugii2, 1Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

    Background/Purpose: Histopathological confirmation is required for the diagnosis of systemic vasculitis. However, patients suspected of vasculitis often only have lesions with a low diagnostic yield…
  • Abstract Number: 1695 • 2014 ACR/ARHP Annual Meeting

    Validation of Vesmeter As a Diagnostic Tool of Scleroderma

    Yoshihiro Hishitani1,2, Yoshihito Shima1, Toshio Tanaka1 and Atsushi Kumanogoh1, 1Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 2Internal Medicine, Kinki Central Hospital, Itami, Japan

    Background/Purpose: Objective method to evaluate the skin involvement in the patients with scleroderma has not been definitely established. We have developed Vesmeter, a computer-linked device…
  • Abstract Number: 1691 • 2014 ACR/ARHP Annual Meeting

    Systemic Sclerosis Patients with Pulmonary Hypertension Have a Lower Change in End Tidal Carbon Dioxide Following Three Minutes of Step Exercise Than Systemic Sclerosis Patients without Pulmonary Hypertension: A Cross-Sectional Study

    Elana J. Bernstein1, Jessica K. Gordon2, Robert F. Spiera2, Wei-Ti Huang3, Evelyn M. Horn4 and Lisa A. Mandl2, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Biostatistics, Hospital for Special Surgery, New York, NY, 4Cardiology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY

    Background/Purpose: Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc).  Transthoracic echocardiogram and pulmonary function testing are standard noninvasive…
  • Abstract Number: 1629 • 2014 ACR/ARHP Annual Meeting

    Added Value of the Determination of Anti-Ribosomal and Anti-Ku Antibodies for Diagnosis of Systemic Lupus Erythematosus

    Johannes Schulte-Pelkum1, Diana Carmona-Fernandes2, Maria Jose Santos2, Roger Albesa1 and Michael Mahler1, 1Research, INOVA Diagnostics, San Diego, CA, 2Rheumatology Research Unit Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

    Background/Purpose Anti-dsDNA antibodies (aab) are known as important serological marker to aid in the diagnosis of systemic lupus erythematosus (SLE) and are part of the…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology